Nephros financials
$3.89−3.47%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $6.0M | $5.2M | $4.7M | $4.8M | $4.4M | $4.9M | $3.9M | $3.5M | $3.3M | $3.5M | $3.3M | $3.7M |
| Gross profit | $4.0M | $3.0M | $2.8M | $2.9M | $2.8M | $3.2M | $2.5M | $2.1M | $1.9M | $2.2M | $2.0M | $2.2M |
| Gross margin | 66.9% | 57.4% | 58.4% | 61.2% | 63.2% | 64.7% | 64.0% | 61.1% | 58.8% | 62.1% | 62.1% | 58.6% |
| Operating income | $1.2M | $97.0K | $18.0K | $314.0K | $248.0K | $566.0K | $317.0K | $206.0K | -$317.0K | -$200.0K | -$649.0K | -$203.0K |
| Net income | $1.2M | $140.0K | $62.0K | $337.0K | $237.0K | $558.0K | $349.0K | $183.0K | -$289.0K | -$169.0K | -$654.0K | -$182.0K |
| Net margin | 19.9% | 2.7% | 1.3% | 7.1% | 5.4% | 11.4% | 9.0% | 5.2% | −8.9% | −4.8% | −20.1% | −4.9% |
| Diluted EPS | $0.11 | $0.01 | $0.01 | $0.03 | $0.02 | $0.05 | $0.03 | $0.02 | $-0.03 | $-0.02 | $-0.06 | $-0.02 |
| EBITDA | $1.2M | $124.0K | $50.0K | $348.0K | $281.0K | $606.0K | $352.0K | $239.0K | -$282.0K | -$166.0K | -$598.0K | -$147.0K |
| Operating cash flow | $681.0K | -$1.7M | $230.0K | $99.0K | $994.0K | $322.0K | $1.3M | -$623.0K | -$501.0K | -$672.0K | -$237.0K | $562.0K |
| Free cash flow | $681.0K | -$1.7M | $230.0K | $99.0K | $994.0K | $322.0K | $1.3M | -$623.0K | -$556.0K | -$672.0K | -$312.0K | $562.0K |
| Diluted shares | 11.1M | 11.0M | 11.4M | 11.0M | 10.8M | 10.6M | 10.8M | 10.6M | 10.5M | 10.5M | 10.5M | 10.5M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $4.7M | $4.0M | $5.4M | $5.2M | $5.1M | $4.1M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total assets | $15.8M | $13.8M | $13.6M | $13.2M | $12.2M | $11.8M |
| Total liabilities | $3.8M | $3.1M | $3.4M | $3.2M | $2.6M | $2.5M |
| Shareholders' equity | $12.0M | $10.7M | $10.2M | $10.0M | $9.6M | $9.3M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology